Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
___________________________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
___________________________________
Date of Report (Date of earliest event reported): November 1, 2017
CVR PARTNERS, LP
(Exact name of registrant as specified in its charter)
|
| | |
Delaware (State or other jurisdiction of incorporation) | 001-35120 (Commission File Number) | 56-2677689 (I.R.S. Employer Identification Number) |
| 2277 Plaza Drive, Suite 500 Sugar Land, Texas 77479
(Address of principal executive offices, including zip code) | |
Registrant’s telephone number, including area code: (281) 207-3200
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Item 2.02. Results of Operations and Financial Condition.
On November 1, 2017, CVR Partners, LP (the “Partnership”) posted a presentation to its website at www.cvrpartners.com under the tab “Investor Relations” providing information regarding its results of operations and financial condition for the quarter and nine months ended September 30, 2017. The presentation is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information in Item 2.02 and Item 7.01 of this Current Report on Form 8-K and Exhibit 99.1 attached hereto is being "furnished" and is not deemed "filed" by the Partnership for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section, nor is it deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.
Item 7.01. Regulation FD Disclosure.
The information set forth under Item 2.02 is incorporated by reference as if fully set forth herein.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits
|
| |
Exhibit Number |
Exhibit Description |
| |
| |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: November 1, 2017
|
| |
CVR Partners, LP |
By: CVR GP, LLC, its general partner |
| |
By: | /s/ Susan M. Ball |
| Susan M. Ball, |
| Chief Financial Officer and Treasurer |
uanq32017earningspres963
CVR Partners, LP
3rd Quarter 2017 Earnings Report
November 1, 2017
1
The following presentation contains forward-looking statements based on management’s
current expectations and beliefs, as well as a number of assumptions concerning future
events. The assumptions and estimates underlying forward-looking statements are inherently
uncertain and, although considered reasonable as of the date of preparation by the
management team of our general partner, are subject to a wide variety of significant business,
economic, and competitive risks and uncertainties that could cause actual results to differ
materially from those contained in the prospective information. Accordingly, there can be no
assurance that we will achieve the future results we expect or that actual results will not differ
materially from expectations.
You are cautioned not to put undue reliance on such forward-looking statements (including
forecasts and projections regarding our future performance) because actual results may vary
materially from those expressed or implied as a result of various factors, including, but not
limited to those set forth under “Risk Factors” in CVR Partners, LP’s Annual Report on Form
10-K, Quarterly Reports on Form 10-Q and any other filings CVR Partners, LP makes with the
Securities and Exchange Commission.
CVR Partners, LP assumes no obligation to, and expressly disclaims any obligation to, update
or revise any forward-looking statements, whether as a result of new information, future events
or otherwise, except as required by law.
Safe Harbor Statement
2
Consolidated Selected Financials
(All information in this earnings report is unaudited other than the balance sheet data as of December 31, 2016)
(1) Definition of this non-GAAP financial measure is on slide 7.
(2) Reconciliation of this non-GAAP financial measure to the most directly comparable GAAP measure is on slide 8.
Consolidated Financial Results and Cash Flow Data
(In millions)
9/30/2017 9/30/2016 9/30/2017 9/30/2016
Net Sales 69.4$ 78.5$ 252.6$ 271.4$
Operating Income (loss) (15.9)$ 2.4$ 1.6$ 25.8$
Net Loss (31.6)$ (13.4)$ (45.4)$ (12.4)$
Adjusted EBITDA (1)(2) 5.0$ 17.4$ 58.1$ 74.4$
Cash Flow Provided By Operations 21.1$ 18.4$ 28.1$ 47.5$
Cash Flow Used In Investing Activities (2.8)$ (6.4)$ (11.4)$ (82.1)$
Cash Flow Provided By (Used In) Financing Activities -$ (23.0)$ (2.3)$ 49.9$
Net Increase (Decrease) In Cash and Cash Equivalents 18.3$ (11.0)$ 14.4$ 15.3$
Maintenance Capital Expenditures 2.7$ 3.4$ 11.1$ 8.3$
Growth Capital Expenditures 0.1$ 3.0$ 0.3$ 10.0$
Total Capital Expenditures 2.8$ 6.4$ 11.4$ 18.3$
Balance Sheet
(In millions)
9/30/2017 12/31/2016
Cash and Cash Equivalents 70.0$ 55.6$
Working Capital 73.3$ 71.5$
Total Assets 1,275.8$ 1,312.2$
Total Debt, including current portion 625.2$ 623.1$
Partners' Capital 577.3$ 624.9$
Third Quarter Year to Date
as of
On April 1, 2016, CVR Partners, LP (the
"Partnership") completed the merger (the "East
Dubuque Merger") whereby the Partnership
acquired a nitrogen fertilizer manufacturing
facility located in East Dubuque, Illinois (the
"East Dubuque Facility").
The consolidated financial statements and key
financial metrics contained in this presentation
include the results of the East Dubuque Facility
beginning on April 1, 2016, the date of the
closing of the acquisition.
3
Key Performance Indicators
Coffeyville On-Stream Rates(1) East Dubuque On-Stream Rates(2)
Consolidated Sales (thousand tons) Consolidated Product Pricing at Gate ($ / ton)
(1) The Linde air separation unit experienced a shut down during the second quarter of 2017. Following the Linde outage, the Coffeyville Facility UAN unit experienced a number
of operational challenges, resulting in approximately 11 days of UAN downtime during the three months ended June 30, 2017. Excluding the impact of the Linde air separation
unit outage at the Coffeyville Facility, the UAN unit on-stream factor at the Coffeyville Facility would have been 99.5% for the three months ended June 30, 2017.
(2) During the third quarter of 2017, the East Dubuque Facility completed a scheduled turnaround and the ammonia and UAN units were down for approximately 14 days.
Excluding the impact of the full facility turnaround at the East Dubuque Facility, the on-stream factors at the East Dubuque Facility would have been 91.3% for ammonia and
91.8% for UAN for the three months ended September 30, 2017.
4
Capital Structure and Debt Metrics
(1) Amounts presented are gross debt not net of unamortized debt issuance costs or unamortized discount.
(2) Net debt is defined as total debt less cash and cash equivalents.
(3) Reconciliation of this non-GAAP financial measure to the most directly comparable GAAP measure is on slide 9.
LTM LTM
Q2 2017 Q3 2017
Cash and Cash Equivalents 51.7$ 70.0$
Total Debt, Including Current Portion (1) 647.2$ 647.2$
Net Debt (2) 595.5$ 577.2$
Partners' Capital 608.9$ 577.3$
Adjusted EBITDA(3) 88.8$ 76.4$
Debt to Capital 52% 53%
Net Debt to Capital, Net of Cash 49% 50%
Debt to Adjusted EBITDA 7.3 8.5
Net Debt to Adjusted EBITDA 6.7 7.6
($ in millions, except ratios)
5
Capital Spending
YTD
($ in millions) 2014 2015 2016
YTD Q3
2017
2017
Estimate
Maintenance 4.7$ 9.6$ 13.7$ 11.1$ 15.0$
Profit and Growth 16.4 7.4 9.5 0.3 0.5
Total Capital Spending 21.1$ 17.0$ 23.2$ 11.4$ 15.5$
Appendix
7
To supplement the actual results in accordance with GAAP for the applicable periods, the
Partnership also uses non-GAAP financial measures as discussed below, which are reconciled
to GAAP-based results. These non-GAAP financial measures should not be considered an
alternative for GAAP results. The adjustments are provided to enhance an overall
understanding of the Partnership’s financial performance for the applicable periods and are
indicators management believes are relevant and useful for planning and forecasting future
periods.
EBITDA and Adjusted EBITDA. EBITDA represents net income (loss) before (i) interest
expense and other financing costs, net of interest income, (ii) income tax expense and (iii)
depreciation and amortization. Adjusted EBITDA represents EBITDA adjusted for share-based
compensation, non-cash; major scheduled turnaround expenses; gain or loss on
extinguishment of debt; loss on disposition of assets; expenses associated with the East
Dubuque Merger and business interruption insurance recovery. We present Adjusted EBITDA
because it is the starting point for our calculation of available cash for distribution. EBITDA
and Adjusted EBITDA are not recognized terms under GAAP and should not be substituted for
net income or cash flow from operations. Management believes that EBITDA and Adjusted
EBITDA enable investors to better understand our ability to make distributions to our common
unitholders, help investors evaluate our ongoing operating results and allow for greater
transparency in reviewing our overall financial, operational and economic performance.
EBITDA and Adjusted EBITDA presented by other companies may not be comparable to our
presentation, since each company may define these terms differently.
Non-GAAP Financial Measures
8
Non-GAAP Financial Measures
(1) Definition of this non-GAAP financial measure is on slide 7
($ in millions) 9/30/2017 9/30/2016 9/30/2017 9/30/2016
Net loss (31.6)$ (13.4)$ (45.4)$ (12.4)$
Interest expense and other financing costs, net 15.7 15.6 47.1 32.8
Depreciation and amortization 19.5 16.4 54.9 41.0
Income tax expense - 0.2 - 0.3
EBITDA(1) 3.6$ 18.8$ 56.6$ 61.7$
Major scheduled turnaround expenses 2.5 - 2.6 6.6
Loss on extinguishment of debt - - - 5.1
Expenses associated with the East Dubuque Merger - 0.7 - 3.1
Insurance recovery - business interruption (1.1) (2.1) (1.1) (2.1)
Adjusted EBITDA (1) 5.0$ 17.4$ 58.1$ 74.4$
Third Quarter Year to Date
9
Non-GAAP Financial Measures
(1) Definition of this non-GAAP financial measure is on slide 7
($ in millions) Q3 2016 Q4 2016 Q1 2017 Q2 2017 Q3 2017
Net loss (13.4)$ (14.5)$ (10.3)$ (3.5)$ (31.6)$
Interest expense and other financing costs, net 15.6 15.8 15.7 15.7 15.7
Depreciation and amortization 16.4 17.2 15.4 20.0 19.5
Income tax expense 0.2 - - - -
EBITDA(1) 18.8$ 18.5$ 20.8$ 32.2$ 3.6$
Major scheduled turnaround expenses - - - 0.1 2.5
Share-based compensation, non-cash - - - - -
Gain on extinguishment of debt - (0.2) - - -
Expenses associated with the East Dubuque Merger 0.7 - - - -
Insurance recovery - business interruption (2.1) - - - (1.1)
Adjusted EBITDA (1) 17.4$ 18.3$ 20.8$ 32.3$ 5.0$
LTM LTM
($ in millions) Q2 2017 Q3 2017
Net loss (41.7)$ (59.9)$
Interest expense and other financing costs, net 62.8 62.9
Depreciation and amortization 69.0 72.1
Income tax expense 0.2 -
EBITDA(1) 90.3$ 75.1$
Major scheduled turnaround expenses 0.1 2.6
Share-based compensation, non-cash - -
Gain on extinguishment of debt (0.2) (0.2)
Expenses associated with the East Dubuque Merger 0.7 -
Insurance recovery - business interruption (2.1) (1.1)
Adjusted EBITDA (1) 88.8$ 76.4$